Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AZSTARYS safely and effectively. See full prescribing information for AZSTARYS. AZSTARYS (serdexmethylphenidate and dexmethylphenidate) capsules, for oral use, CII Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
AZSTARYS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.
- generic_name
- serdexmethylphenidate and dexmethylphenidate
- product_names
- Serdexmethylphenidate and Dexmethylphenidate
- ndc
- 65038-286, 65038-286-99, 65038-429, 65038-429-99, 65038-561, 65038-561-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en